Italia markets closed

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
108,57+0,32 (+0,30%)
Alla chiusura: 04:00PM EDT
109,90 +1,33 (+1,23%)
Dopo ore: 07:54PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente108,25
Aperto108,56
Denaro108,25 x 500
Domanda108,64 x 100
Min-Max giorno107,00 - 109,43
Intervallo di 52 settimane89,00 - 201,17
Volume35.653.154
Media Volume2.435.406
Capitalizzazione17,295B
Beta (mensile su 5 anni)1,20
Rapporto PE (ttm)N/D
EPS (ttm)-8,15
Prossima data utili07 ago 2024 - 12 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A145,87
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera